P1304: THE NOVEL TUMOR SUPPRESSOR SAMHD1 CONTRIBUTES TO ANTI-TUMOR RESPONSES IN A CGAS-STING-DEPENDENT OR INDEPENDENT PATHWAY IN HODGKIN LYMPHOMA (HL)

P1304: THE NOVEL TUMOR SUPPRESSOR SAMHD1 CONTRIBUTES TO ANTI-TUMOR RESPONSES IN A CGAS-STING-DEPENDENT OR INDEPENDENT PATHWAY IN HODGKIN LYMPHOMA (HL)

Bibliographic Details
Main Authors:	I. Xagoraris, G. Kokaraki, K. Stathopoulou, P. Xyderou, A. Kurzay, N. Herold, A. Lundqvist, G. Z. Rassidakis
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000848080.23589.90

Similar Items

P053: The cGAS-STING anti-tumor immune response pathway as a potential therapeutic target in classical Hodgkin Lymphoma (cHL)
by: Ioanna Xagoraris, et al.
Published: (2022-10-01)

P052: Targeting CSN5/JAB1 oncogene in classical Hodgkin Lymphoma (cHL)
by: Ioanna Xagoraris, et al.
Published: (2022-10-01)

Sting Is Commonly and Differentially Expressed in T- and Nk-Cell but Not B-Cell Non-Hodgkin Lymphomas
by: Ioanna Xagoraris, et al.
Published: (2022-02-01)

Restriction by SAMHD1 limits cGAS/STING-dependent innate and adaptive immune responses to HIV-1
by: Maelfait, J, et al.
Published: (2016)

Restriction by SAMHD1 Limits cGAS/STING-Dependent Innate and Adaptive Immune Responses to HIV-1
by: Jonathan Maelfait, et al.
Published: (2016-08-01)

PB2171: THE NOVEL CSN5/JAB1 INHIBITOR CSN5I-3 SUPPRESSES CELL GROWTH AND UPREGULATES GENE EXPRESSION OF TYPE-I INTERFERONS (IFN) IN ANAPLASTIC LARGE CELL LYMPHOMA (ALCL)
by: I. Xagoraris, et al.
Published: (2022-06-01)

cGAS-STING signalings potentiate tumor progression via sustaining cancer stemness
by: Fu-rao Liu, et al.
Published: (2022-06-01)

P1283: CIRCULATING IMMUNE CELLS IN CLASSICAL HODGKIN LYMPHOMA IN RELATION TO TUMOR BURDEN AND TREATMENT
by: T. A. Mulder, et al.
Published: (2022-06-01)

SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma
by: Yangyi Li, et al.
Published: (2022-12-01)

Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy
by: Joseph R. Podojil, et al.
Published: (2022-08-01)

598 Reversal of epigenetic silencing of cGAS and STING in melanoma enhances the activity of tumor infiltrating lymphocytes
by: Shari Pilon-Thomas, et al.
Published: (2020-11-01)

cGAS-STING pathway in cancer biotherapy
by: Yang Wang, et al.
Published: (2020-09-01)

Immune Biomarkers in the Peripheral Blood and Tumor Microenvironment of Classical Hodgkin Lymphoma Patients in Relation to Tumor Burden and Response to Treatment
by: Tom A. Mulder, et al.
Published: (2022-11-01)

The cGAS Paradox: Contrasting Roles for cGAS-STING Pathway in Chromosomal Instability
by: Christy Hong, et al.
Published: (2019-10-01)

Remodeling of Tumor Microenvironment by Nanozyme Combined cGAS–STING Signaling Pathway Agonist for Enhancing Cancer Immunotherapy
by: Wenpei Dong, et al.
Published: (2023-09-01)

TRABID inhibition activates cGAS/STING-mediated anti-tumor immunity through mitosis and autophagy dysregulation
by: Yu-Hsuan Chen, et al.
Published: (2023-05-01)

A protein-based cGAS-STING nanoagonist enhances T cell-mediated anti-tumor immune responses
by: Xuan Wang, et al.
Published: (2022-09-01)

cGAS–STING cytosolic DNA sensing pathway is suppressed by JAK2-STAT3 in tumor cells
by: Manuel Adrian Suter, et al.
Published: (2021-03-01)

cGAS-STING triggers inflammaging-associated neurodegeneration
by: José M. Izquierdo
Published: (2023-10-01)

Significance of the cGAS-STING Pathway in Health and Disease
by: Jinglin Zhou, et al.
Published: (2023-08-01)

Role of cGAS–Sting Signaling in Alzheimer’s Disease
by: Manoj Govindarajulu, et al.
Published: (2023-05-01)

Telomere Maintenance and the cGAS-STING Pathway in Cancer
by: Hiroshi Ebata, et al.
Published: (2022-06-01)

The Activation of cGAS-STING in Acute Kidney Injury
by: Sun C, et al.
Published: (2023-10-01)

Intercellular transmission of cGAS-STING signaling in cancer
by: Qirou Wu, et al.
Published: (2023-02-01)

Sensing of viral lung infections by cGAS-STING
by: Lei Fang, et al.
Published: (2022-05-01)

cGAS/STING: novel perspectives of the classic pathway
by: Menghui Gao, et al.
Published: (2020-09-01)

cGAS-STING, an important pathway in cancer immunotherapy
by: Minlin Jiang, et al.
Published: (2020-06-01)

The Complexity of the cGAS-STING Pathway in CNS Pathologies
by: Amelia L. Fryer, et al.
Published: (2021-02-01)

TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer
by: Hongwei Lv, et al.
Published: (2024-01-01)

Medicinal plant-derived mtDNA via nanovesicles induces the cGAS-STING pathway to remold tumor-associated macrophages for tumor regression
by: Jinfeng Liu, et al.
Published: (2023-03-01)

Chikungunya virus antagonizes cGAS-STING mediated type-I interferon responses by degrading cGAS.
by: L G Webb, et al.
Published: (2020-10-01)

P032: Circulating immune biomarkers in classical Hodgkin lymphoma in relation to tumor burden and response to treatment.
by: Tom A. Mulder, et al.
Published: (2022-10-01)

Porcine cGAS-STING signaling induced autophagy inhibits STING downstream IFN and apoptosis
by: Nengwen Xia, et al.
Published: (2022-10-01)

cGAS–STING, an important signaling pathway in diseases and their therapy
by: Qijie Li, et al.
Published: (2024-04-01)

Erratum to Intercellular transmission of cGAS-STING signaling in cancer
by: Qirou Wu, et al.
Published: (2023-04-01)

cGAS-independent STING activation in response to DNA damage
by: Leonie Unterholzner, et al.
Published: (2019-07-01)

cGAS‐STING signaling in cancer: Regulation and therapeutic targeting
by: Xinzou Fan, et al.
Published: (2023-09-01)

Updated roles of cGAS-STING signaling in autoimmune diseases
by: Ya Liu, et al.
Published: (2023-09-01)

cGAS-STING signaling pathway in intestinal homeostasis and diseases
by: Yuchen Yang, et al.
Published: (2023-09-01)

Cancer immunotherapy strategies that target the cGAS-STING pathway
by: Zhuoying Tian, et al.
Published: (2022-10-01)